References
Asawakarn T, Cladera J, & O’Shea P (2001). Effects of the membrane
dipole potential on the interaction of saquinavir with phospholipid
membranes and plasma membrane receptors of Caco-2 cells. J Biol Chem
276: 38457-38463.
Aykan DA, & Seyithanoglu M (2019). The effects of administration of
vitamin D, infliximab, and leflunomide on testosterone concentrations in
rats under atorvastatin therapy. Eurasian J Med 51: 224-227.
Bjorkhem-Bergman L, Lindh JD, & Bergman P (2011). What is a relevant
statin concentration in cell experiments claiming pleiotropic effects?
Br J Clin Pharmacol 72: 164-165.
Cladera J, & O’Shea P (1998). Intramembrane molecular dipoles affect
the membrane insertion and folding of a model amphiphilic peptide.
Biophys J 74: 2434-2442.
Clarke RJ (2015). Dipole-potential-mediated effects on ion pump
kinetics. Biophys J 109: 1513-1520.
Clarke RJ, & Kane DJ (1997). Optical detection of membrane dipole
potential: avoidance of fluidity and dye-induced effects. Biochimica et
biophysica acta 1323: 223-239.
Corsini A, Maggi FM, & Catapano AL (1995). Pharmacology of competitive
inhibitors of HMG-CoA reductase. Pharmacol Res 31: 9-27.
Crismaru I, Pantea Stoian A, Bratu OG, Gaman MA, Stanescu AMA, Bacalbasa
N, et al. (2020). Low-density lipoprotein cholesterol lowering
treatment: the current approach. Lipids Health Dis 19: 85.
Dawaliby R, Trubbia C, Delporte C, Noyon C, Ruysschaert JM, Van
Antwerpen P, et al. (2016). Phosphatidylethanolamine is a key
regulator of membrane fluidity in eukaryotic cells. J Biol Chem
291: 3658-3667.
Derossi D, Joliot AH, Chassaing G, & Prochiantz A (1994). The third
helix of the Antennapedia homeodomain translocates through biological
membranes. J Biol Chem 269: 10444-10450.
Dobson PD, & Kell DB (2008). Carrier-mediated cellular uptake of
pharmaceutical drugs: an exception or the rule? Nat Rev Drug Discov
7: 205-220.
Endo A, & Kuroda M (1976). Citrinin, an inhibitor of cholesterol
synthesis. J Antibiot (Tokyo) 29: 841-843.
Endo A, Tsujita Y, Kuroda M, & Tanzawa K (1977). Inhibition of
cholesterol synthesis in vitro and in vivo by ML-236A and ML-236B,
competitive inhibitors of 3-hydroxy-3-methylglutaryl-coenzyme A
reductase. Eur J Biochem 77: 31-36.
Erazo-Oliveras A, Muthukrishnan N, Baker R, Wang TY, & Pellois JP
(2012). Improving the endosomal escape of cell-penetrating peptides and
their cargos: strategies and challenges. Pharmaceuticals (Basel)
5: 1177-1209.
Fievet C, & Staels B (2009). Combination therapy of statins and
fibrates in the management of cardiovascular risk. Curr Opin Lipidol
20: 505-511.
Flewelling RF, & Hubbell WL (1986). The membrane dipole potential in a
total membrane potential model. Applications to hydrophobic ion
interactions with membranes. Biophys J 49: 541-552.
Fominaya J, Bravo J, & Rebollo A (2015). Strategies to stabilize cell
penetrating peptides for in vivo applications. Ther Deliv 6:1171-1194.
Futaki S (2006). Oligoarginine vectors for intracellular delivery:
design and cellular-uptake mechanisms. Biopolymers 84: 241-249.
Göbel A, Breining D, Rauner M, Hofbauer LC, & Rachner TD (2019).
Induction of 3-hydroxy-3-methylglutaryl-CoA reductase mediates statin
resistance in breast cancer cells. Cell Death Dis 10: 91.
Gross E, Bedlack RS, Jr., & Loew LM (1994). Dual-wavelength ratiometric
fluorescence measurement of the membrane dipole potential. Biophys J
67: 208-216.
Guidotti G, Brambilla L, & Rossi D (2017). Cell-penetrating peptides:
from basic research to clinics. Trends Pharmacol Sci 38:406-424.
Haldar S, Kanaparthi RK, Samanta A, & Chattopadhyay A (2012).
Differential effect of cholesterol and its biosynthetic precursors on
membrane dipole potential. Biophys J 102: 1561-1569.
Jiang T, Olson ES, Nguyen QT, Roy M, Jennings PA, & Tsien RY (2004).
Tumor imaging by means of proteolytic activation of cell-penetrating
peptides. Proc Natl Acad Sci U S A 101: 17867-17872.
Joliot A, Pernelle C, Deagostini-Bazin H, & Prochiantz A (1991).
Antennapedia homeobox peptide regulates neural morphogenesis. Proc Natl
Acad Sci U S A 88: 1864-1868.
Jones P, Kafonek S, Laurora I, & Hunninghake D (1998). Comparative dose
efficacy study of atorvastatin versus simvastatin, pravastatin,
lovastatin, and fluvastatin in patients with hypercholesterolemia (the
CURVES study). Am J Cardiol 81: 582-587.
Kalliokoski A, & Niemi M (2009). Impact of OATP transporters on
pharmacokinetics. Br J Pharmacol 158: 693-705.
Kimbung S, Lettiero B, Feldt M, Bosch A, & Borgquist S (2016). High
expression of cholesterol biosynthesis genes is associated with
resistance to statin treatment and inferior survival in breast cancer.
Oncotarget 7: 59640-59651.
Kovács T, Batta G, Hajdu T, Szabó A, Váradi T, Zákány F, et al.(2016). The dipole potential modifies the clustering and ligand binding
affinity of ErbB proteins and their signaling efficiency. Sci Rep
6: 35850.
Kovács T, Batta G, Zákány F, Szöllősi J, & Nagy P (2017). The dipole
potential correlates with lipid raft markers in the plasma membrane of
living cells. J Lipid Res 58: 1681-1691.
Kuhry JG, Fonteneau P, Duportail G, Maechling C, & Laustriat G (1983).
TMA-DPH: a suitable fluorescence polarization probe for specific plasma
membrane fluidity studies in intact living cells. Cell biophysics
5: 129-140.
Lonn P, Kacsinta AD, Cui XS, Hamil AS, Kaulich M, Gogoi K, et al.(2016). Enhancing Endosomal Escape for Intracellular Delivery of
Macromolecular Biologic Therapeutics. Sci Rep 6: 32301.
Luo P, Wang L, Zhu H, Du S, Wang G, & Ding S (2016). Impact of
atorvastatin combined with ezetimibe for the treatment of carotid
atherosclerosis in patients with coronary heart disease. Acta Cardiol
Sin 32: 578-585.
Najjar K, Erazo-Oliveras A, Brock DJ, Wang TY, & Pellois JP (2017). An
l- to d-Amino Acid Conversion in an Endosomolytic Analog of the
Cell-penetrating Peptide TAT Influences Proteolytic Stability, Endocytic
Uptake, and Endosomal Escape. J Biol Chem 292: 847-861.
Nakase I, Kogure K, Harashima H, & Futaki S (2011). Application of a
fusiogenic peptide GALA for intracellular delivery. Methods Mol Biol
683: 525-533.
O’Shea P (2003). Intermolecular interactions with/within cell membranes
and the trinity of membrane potentials: kinetics and imaging. Biochem
Soc Trans 31: 990-996.
Parasassi T, De Stasio G, Ravagnan G, Rusch RM, & Gratton E (1991).
Quantitation of lipid phases in phospholipid vesicles by the generalized
polarization of Laurdan fluorescence. Biophys J 60: 179-189.
Pearlstein RA, Dickson CJ, & Hornak V (2017). Contributions of the
membrane dipole potential to the function of voltage-gated cation
channels and modulation by small molecule potentiators. Biochimica et
biophysica acta 1859: 177-194.
Poon GM, & Gariepy J (2007). Cell-surface proteoglycans as molecular
portals for cationic peptide and polymer entry into cells. Biochem Soc
Trans 35: 788-793.
Qian Z, Dougherty PG, & Pei D (2015). Monitoring the cytosolic entry of
cell-penetrating peptides using a pH-sensitive fluorophore. Chemical
Communications 51: 2162-2165.
Qian Z, Martyna A, Hard RL, Wang J, Appiah-Kubi G, Coss C, et al.(2016). Discovery and mechanism of highly efficient cyclic
cell-penetrating peptides. Biochemistry 55: 2601-2612.
Repke H, & Bienert M (1987). Mast cell activation–a
receptor-independent mode of substance P action? FEBS Lett 221:236-240.
Rothbard JB, Jessop TC, & Wender PA (2005). Adaptive translocation: the
role of hydrogen bonding and membrane potential in the uptake of
guanidinium-rich transporters into cells. Adv Drug Deliv Rev
57: 495-504.
Sarkar P, Chakraborty H, & Chattopadhyay A (2017). Differential
membrane dipolar orientation induced by acute and chronic cholesterol
depletion. Sci Rep 7: 4484.
Schachter M (2005). Chemical, pharmacokinetic and pharmacodynamic
properties of statins: an update. Fundam Clin Pharmacol 19:117-125.
Schaefer EJ, McNamara JR, Tayler T, Daly JA, Gleason JL, Seman LJ,
et al. (2004). Comparisons of effects of statins (atorvastatin,
fluvastatin, lovastatin, pravastatin, and simvastatin) on fasting and
postprandial lipoproteins in patients with coronary heart disease versus
control subjects. Am J Cardiol 93: 31-39.
Sidaway JE, Davidson RG, McTaggart F, Orton TC, Scott RC, Smith
GJ, et al. (2004). Inhibitors of 3-hydroxy-3-methylglutaryl-CoA
reductase reduce receptor-mediated endocytosis in opossum kidney cells.
J Am Soc Nephrol 15: 2258-2265.
Simon SA, McIntosh TJ, Magid AD, & Needham D (1992). Modulation of the
interbilayer hydration pressure by the addition of dipoles at the
hydrocarbon/water interface. Biophys J 61: 786-799.
Starke-Peterkovic T, Turner N, Vitha MF, Waller MP, Hibbs DE, & Clarke
RJ (2006). Cholesterol effect on the dipole potential of lipid
membranes. Biophys J 90: 4060-4070.
Thoren PE, Persson D, Esbjorner EK, Goksor M, Lincoln P, & Norden B
(2004). Membrane binding and translocation of cell-penetrating peptides.
Biochemistry 43: 3471-3489.
van den Brand D, Veelken C, Massuger L, & Brock R (2018). Penetration
in 3D tumor spheroids and explants: Adding a further dimension to the
structure-activity relationship of cell-penetrating peptides. Biochim
Biophys Acta Biomembr 1860: 1342-1349.
Via MA, Del Popolo MG, & Wilke N (2018). Negative dipole potentials and
carboxylic polar head groups foster the insertion of cell-penetrating
peptides into lipid monolayers. Langmuir 34: 3102-3111.
Via MA, Klug J, Wilke N, Mayorga LS, & Del Popolo MG (2018). The
interfacial electrostatic potential modulates the insertion of
cell-penetrating peptides into lipid bilayers. Phys Chem Chem Phys
20: 5180-5189.
Wallbrecher R, Depre L, Verdurmen WP, Bovee-Geurts PH, van Duinkerken
RH, Zekveld MJ, et al. (2014). Exploration of the design
principles of a cell-penetrating bicylic peptide scaffold. Bioconjug
Chem 25: 955-964.
Wang F, Wang Y, Zhang X, Zhang W, Guo S, & Jin F (2014). Recent
progress of cell-penetrating peptides as new carriers for intracellular
cargo delivery. J Control Release 174: 126-136.
Wang L (2012). Measurements and implications of the membrane dipole
potential. Annual review of biochemistry 81: 615-635.
Wu X, Whitfield LR, & Stewart BH (2000). Atorvastatin transport in the
Caco-2 cell model: contributions of P-glycoprotein and the
proton-monocarboxylic acid co-transporter. Pharm Res 17:209-215.
Yilmaz A, Reiss C, Weng A, Cicha I, Stumpf C, Steinkasserer A, et
al. (2006). Differential effects of statins on relevant functions of
human monocyte-derived dendritic cells. J Leukoc Biol 79:529-538.
Zákány F, Kovács T, Panyi G, & Varga Z (2020). Direct and indirect
cholesterol effects on membrane proteins with special focus on potassium
channels. Biochim Biophys Acta Mol Cell Biol Lipids 1865:158706.
Zhang J, Li Q, Wu Y, Wang D, Xu L, Zhang Y, et al. (2019).
Cholesterol content in cell membrane maintains surface levels of ErbB2
and confers a therapeutic vulnerability in ErbB2-positive breast cancer.
Cell Commun Signal 17: 15.
Ziegler A (2008). Thermodynamic studies and binding mechanisms of
cell-penetrating peptides with lipids and glycosaminoglycans. Adv Drug
Deliv Rev 60: 580-597.